0000950142-18-001159.txt : 20180514 0000950142-18-001159.hdr.sgml : 20180514 20180514102954 ACCESSION NUMBER: 0000950142-18-001159 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180331 FILED AS OF DATE: 20180514 DATE AS OF CHANGE: 20180514 EFFECTIVENESS DATE: 20180514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aisling Capital LLC CENTRAL INDEX KEY: 0001571076 IRS NUMBER: 010849048 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-15878 FILM NUMBER: 18829106 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 212-651-6372 MAIL ADDRESS: STREET 1: 888 SEVENTH AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001571076 XXXXXXXX 03-31-2018 03-31-2018 false Aisling Capital LLC
888 Seventh Avenue, 12th Floor New York NY 10106
13F HOLDINGS REPORT 028-15878 N
Robert Wenzel Chief Financial Officer 212-651-6374 /s/ Robert Wenzel New York NY 05-14-2018 0 10 561114
INFORMATION TABLE 2 infotable.xml ADMA BIOLOGICS INC. COM 000899104 16598 3608171 SH SOLE 3608171 0 0 AGILE THERAPEUTICS INC. COM 00847L100 3354 1304933 SH SOLE 1304933 0 0 AIMMUNE THERAPEUTICS INC. COM 00900T107 71299 2240000 SH SOLE 2240000 0 0 CHIMERIX INC. COM 16934W106 2459 472943 SH SOLE 472943 0 0 CIDARA THERAPEUTICS INC. COM 171757107 4085 1021148 SH SOLE 1021148 0 0 LOXO ONCOLOGY INC. COM 548862101 396748 3438920 SH SOLE 3438920 0 0 PERNIX THERAPEUTICS HLDGS INC. COM NEW 71426V306 502 210000 SH SOLE 210000 0 0 PERNIX THERAPEUTICS HLDGS INC. DEBT 4.250% 4/0 71426VAK4 1155 2500000 PRN SOLE 2500000 0 0 TRANSENTERIX INC. COM NEW 89366M201 16812 9889352 SH SOLE 9889352 0 0 VIEWRAY INC. COM 92672L107 48102 7480887 SH SOLE 7480887 0 0